论文部分内容阅读
近年来，药物的缓释和控释剂型越来越受到患者的欢迎。尔康必同片（硝苯地平缓释片）是新型的长效钙桔抗剂，临床已用于治疗冠心病和高血压等。本研究采用24小时动态血压监测（ABPM）的方法验证尔康必同的降压持续时间和疗效。对象和方法20例轻中度原发性高血压患者，95MDBPM11
In recent years, drug release and controlled release formulations are increasingly welcomed by patients. Ercan Bi-tablets (nifedipine sustained-release tablets) is a new long-acting calcium citrate anti-agent, has been used clinically for the treatment of coronary heart disease and hypertension. In this study, 24-hour ambulatory blood pressure monitoring (ABPM) was used to validate the duration and efficacy of Corneal antihypertensive therapy. Subjects and Methods Twenty patients with mild to moderate essential hypertension, 95MDBPM11